Café-au-lait macules
Conditions
Interventions
High-energy Q-switched 755nm group:Q-switched 755 nm laser therapy
Low-energy Q-switched 1064 nm group:Q-switched 1064 nm laser therapy
Sponsors
Shanghai Ninth People's Hospital,Shanghai JiaoTong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with untreated café-au-lait macules; 2.Age >= 1 month; 3.After fully understanding the treatment plan and risks, the patient or their guardian voluntarily signs the informed consent form, agrees to participate in the trial, and cooperates with follow-up visits.
Exclusion criteria
Exclusion criteria: 1.Patients with other diseases associated with café-au-lait macules; 2.Patients with active infection, abscess, or ulceration at the treatment site; 3.Patients allergic to local anesthetics; 4.Pregnant or breastfeeding women; 5.Patients currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective Visual Assessment Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pigment clearance rate;Safety evaluation; | — |
Countries
China
Contacts
Public ContactLin Xiaoxi
Shanghai Ninth People's Hospital,Shanghai JiaoTong University School of Medicine
Outcome results
None listed